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STUDY OBJECTIVE: Hereditary angioedema is a rare disease associated with
unpredictable, recurrent attacks of potentially life-threatening edema. Management
of severe attacks is currently suboptimal because emergency medical teams are
often unaware of new specific treatments. The objective of this trial is to test
whether a dedicated national telephone care-management strategy would reduce
resource use during severe hereditary angioedema attacks.
METHODS: We conducted a cluster-randomized multicenter prospective trial of
patients with a documented diagnosis of hereditary angioedema (type I, II or FXII
hereditary angioedema). Participants were enrolled between March 2013 and June
2014 at 8 participating reference centers. The randomized units were the reference
centers (clusters). Patients in the intervention arm were given a national free
telephone number to call in the event of a severe attack. Emergency physicians in
the SOS-hereditary angiœdema (SOS-HAE) call center were trained to advise or
prescribe specific treatments. The primary outcome was number of admissions for
angioedema attacks. Economic evaluation was also performed.
RESULTS: We included 100 patients in the SOS-HAE group and 100 in the control
group. During the 2 years, there were 2,368 hereditary angioedema attacks among
169 patients (85%). Mean number of hospital admissions per patient in the 2-year
period was significantly greater in the usual-practice group (mean 0.16 [range 0 to
2] versus 0.03 [range 0 to 1]); patient risk difference was significant: -0.13 (95%
confidence interval -0.22 to -0.04; P=.02). Probabilistic sensitivity graphic analysis
indicated a trend toward increased quality-adjusted life-years in the SOS-HAE
group.
CONCLUSION: A national dedicated call center for management of severe
hereditary angioedema attacks is associated with a decrease in hospital admissions
and may be cost-effective if facilities and staff are available to deliver the
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